The California Department of Consumer Affairs and State Board of Pharmacy are allowing pharmacists to collect specimens and order COVID-19 tests in an effort to increase the state’s testing capacity. Specimens will be processed at specialized medical labs.
“Ramping up our testing capacity is critical as we begin modifying our stay at home order,” said Gov. Gavin Newsom in a news release.
The state has conducted more than 1 million diagnostic tests and is currently averaging more than 35,000 tests daily.
More articles on pharmacy:
Drugmakers forced to reshape sales strategy amid pandemic
NIH to test remdesivir in combo with Eli Lilly arthritis drug
Gilead strikes deal to manufacture remdesivir for 127 countries
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.